Kang, E. M., Parta, M., Hilligoss, D., Marquesen, M., Kelly, C., Kwatemaa, A., & Malech, H. L. (2016). Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for High Risk Chronic Granulomatous Disease (CGD) Patients. Biology of Blood & Marrow Transplantation, 22, S327. https://doi.org/10.1016/j.bbmt.2015.11.804
Chicago Style (17th ed.) CitationKang, Elizabeth M., Mark Parta, Dianne Hilligoss, Martha Marquesen, Corin Kelly, Akua Kwatemaa, and Harry L. Malech. "Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for High Risk Chronic Granulomatous Disease (CGD) Patients." Biology of Blood & Marrow Transplantation 22 (2016): S327. https://doi.org/10.1016/j.bbmt.2015.11.804.
MLA (9th ed.) CitationKang, Elizabeth M., et al. "Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for High Risk Chronic Granulomatous Disease (CGD) Patients." Biology of Blood & Marrow Transplantation, vol. 22, 2016, p. S327, https://doi.org/10.1016/j.bbmt.2015.11.804.